首页 > 最新文献

肿瘤研究与临床最新文献

英文 中文
Efficacy comparison between gastrectomy combined with chemotherapy and chemotherapy alone for treatment of advanced gastric cancer with abdominal para-aortic lymph node metastasis 胃切除术联合化疗与单纯化疗治疗晚期癌症腹主动脉旁淋巴结转移的疗效比较
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.11.009
Xue Wang, Jiqing Wang, Song Liu
Objective To investigate the therapeutic effect and prognosis of gastrectomy combined with chemotherapy and chemotherapy alone for treatment of advanced gastric cancer with abdominal para-aortic (the 16th) lymph node metastasis. Methods The clinical data of 236 patients with advanced gastric cancer with abdominal para-aortic (the 16th) lymph node metastasis in Jincheng People's Hospital of Shanxi Province from January 2003 to December 2012 were retrospectively analyzed. According to the treatment method, the patients were divided into chemotherapy alone group (121 cases) and gastrectomy + chemotherapy group (115 cases), and mFOLFOX6 regimen was used for chemotherapy. The efficacy and adverse reactions of the two groups were compared. Results The incidence of upper gastrointestinal adverse events in the gastrectomy+chemotherapy group was higher than that in the chemotherapy alone group [8.7% (10/115) vs. 1.7% (2/121)], and the difference between the two groups was statistically significant (χ 2 = 3.881, P = 0.049). The median overall survival was 14.8 months (10.9-17.8 months) in the chemotherapy alone group and 11.7 months (9.8-15.6 months) in the gastrectomy+chemotherapy group, and there was no significant difference between the two groups (P > 0.05). The 2-year overall survival rate was 32.3% in the chemotherapy alone group and 24.3% in the gastrectomy+chemotherapy group, and there was no significant difference between the two groups (χ 2 = 3.105, P = 0.078). The 2-year progression-free survival rate was 16.5% in the chemotherapy alone group and 20.0% in the gastrectomy+chemotherapy group, and the difference between the two groups was statistically significant (χ 2 = 3.917, P = 0.047). Conclusion Compared with chemotherapy alone, advanced gastric cancer patients with abdominal para-aortic (the 16th) lymph node metastasis could not benefit from gastrectomy combined with chemotherapy. Key words: Stomach neoplasms; Drug therapy, combination; Gastrectomy
目的探讨胃切除术联合化疗及单纯化疗治疗晚期癌症腹主动脉旁(第16)淋巴结转移的疗效及预后。方法回顾性分析2003年1月至2012年12月山西省晋城市人民医院收治的236例晚期癌症腹主动脉旁(第16)淋巴结转移患者的临床资料。根据治疗方法,将患者分为单纯化疗组(121例)和胃切除术+化疗组(115例),采用mFOLFOX6方案进行化疗。比较两组的疗效及不良反应。结果胃癌+化疗组上消化道不良事件发生率高于单纯化疗组[8.7%(10/115)vs.1.7%(2/121)],两组比较差异有统计学意义(χ,2年总生存率单纯化疗组为32.3%,胃切除术+化疗组为24.3%,两组比较无显著性差异(χ2=3.105,P=0.078)。单纯化疗组2年无进展生存率为16.5%,胃切除术+化疗组为20.0%,两组比较有统计学意义(χ2=3.917,P=0.047),晚期癌症合并腹主动脉旁(第16位)淋巴结转移者,胃切除术联合化疗无效。关键词:胃肿瘤;药物治疗,联合用药;胃切除术
{"title":"Efficacy comparison between gastrectomy combined with chemotherapy and chemotherapy alone for treatment of advanced gastric cancer with abdominal para-aortic lymph node metastasis","authors":"Xue Wang, Jiqing Wang, Song Liu","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.11.009","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.11.009","url":null,"abstract":"Objective \u0000To investigate the therapeutic effect and prognosis of gastrectomy combined with chemotherapy and chemotherapy alone for treatment of advanced gastric cancer with abdominal para-aortic (the 16th) lymph node metastasis. \u0000 \u0000 \u0000Methods \u0000The clinical data of 236 patients with advanced gastric cancer with abdominal para-aortic (the 16th) lymph node metastasis in Jincheng People's Hospital of Shanxi Province from January 2003 to December 2012 were retrospectively analyzed. According to the treatment method, the patients were divided into chemotherapy alone group (121 cases) and gastrectomy + chemotherapy group (115 cases), and mFOLFOX6 regimen was used for chemotherapy. The efficacy and adverse reactions of the two groups were compared. \u0000 \u0000 \u0000Results \u0000The incidence of upper gastrointestinal adverse events in the gastrectomy+chemotherapy group was higher than that in the chemotherapy alone group [8.7% (10/115) vs. 1.7% (2/121)], and the difference between the two groups was statistically significant (χ 2 = 3.881, P = 0.049). The median overall survival was 14.8 months (10.9-17.8 months) in the chemotherapy alone group and 11.7 months (9.8-15.6 months) in the gastrectomy+chemotherapy group, and there was no significant difference between the two groups (P > 0.05). The 2-year overall survival rate was 32.3% in the chemotherapy alone group and 24.3% in the gastrectomy+chemotherapy group, and there was no significant difference between the two groups (χ 2 = 3.105, P = 0.078). The 2-year progression-free survival rate was 16.5% in the chemotherapy alone group and 20.0% in the gastrectomy+chemotherapy group, and the difference between the two groups was statistically significant (χ 2 = 3.917, P = 0.047). \u0000 \u0000 \u0000Conclusion \u0000Compared with chemotherapy alone, advanced gastric cancer patients with abdominal para-aortic (the 16th) lymph node metastasis could not benefit from gastrectomy combined with chemotherapy. \u0000 \u0000 \u0000Key words: \u0000Stomach neoplasms; Drug therapy, combination; Gastrectomy","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"760-763"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44566158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy of surgical resection after conversion therapy for advanced gastric cancer 晚期胃癌转化治疗后手术切除的临床疗效观察
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.11.008
Kai Jia, Liwei Wang, Junjie Ma, Jinfeng Ma, Jun Xu
Objective To observe the clinical effect of surgical resection after conversion therapy for patients with advanced gastric cancer. Methods The clinical data of 23 patients with advanced gastric cancer who were admitted to Shanxi Provincial Cancer Hospital from January 2015 to October 2017 were retrospectively analyzed. All patients underwent multi-disciplinary treatment(MDT)-directed conversion therapy, and D2 radical gastrectomy was performed after the disappearance of non-healing factors. The remission of patients after conversion therapy and the related intraoperative and postoperative indicators were analyzed. Results After the conversion therapy, there were 2 cases (8.7%) of complete remission, 13 cases (56.5%) of partial remission and 8 cases (34.8%) of stable disease. The remission rate of the conversion therapy was 65.2% (15/23). In all 23 cases, the surgical time was (135.5±32.1) min, the intraoperative blood loss was (356.7±101.3) ml, the number of lymph nodes resected was 35.5±10.3. The time of gastric tube indwelling was (70.5±29.6) h, the time to first liquid intake was (85.0±21.5) h, the time of drainage tube placement was (196.2±36.2) h and the postoperative hospital stay was (10.7±3.2) d. After surgery, two cases had grade ⅢA post-operative complications and 2 had gradeⅡ. All patients were followed up, the median progression-free survival time was 13.5 months and the median overall survival time was 21.9 months. Conclusion The survival time of patients with advanced gastric cancer can be prolonged by D2 radical gastrectomy after the MDT-guided conversion therapy. Key words: Gastric neoplasms; Surgical procedures, operative; Conversion therapy; Multi-disciplinary team
目的观察中晚期癌症患者转流治疗后手术切除的临床效果。方法回顾性分析山西省癌症医院2015年1月至2017年10月收治的23例晚期癌症患者的临床资料。所有患者均接受了多学科治疗(MDT)指导的转化治疗,在不愈合因素消失后进行D2根治性胃切除术。分析转化治疗后患者病情的缓解情况及术中、术后相关指标。结果转治后病情完全缓解2例(8.7%),部分缓解13例(56.5%),病情稳定8例(34.8%)。转化治疗的缓解率为65.2%(15/23)。23例患者手术时间为(135.5±32.1)min,术中出血量为(356.7±101.3)ml,切除淋巴结数为35.5±10.3。留置胃导管时间为(70.5±29.6)h,首次取液时间为(85.0±21.5)h,放置引流管时间为(196.2±36.2)h,术后住院时间为(10.7±3.2)d。对所有患者进行随访,中位无进展生存时间为13.5个月,中位总生存时间为21.9个月。结论D2根治性胃切除术可延长晚期癌症患者的生存时间。关键词:胃肿瘤;外科手术;转化疗法;多学科团队
{"title":"Clinical efficacy of surgical resection after conversion therapy for advanced gastric cancer","authors":"Kai Jia, Liwei Wang, Junjie Ma, Jinfeng Ma, Jun Xu","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.11.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.11.008","url":null,"abstract":"Objective \u0000To observe the clinical effect of surgical resection after conversion therapy for patients with advanced gastric cancer. \u0000 \u0000 \u0000Methods \u0000The clinical data of 23 patients with advanced gastric cancer who were admitted to Shanxi Provincial Cancer Hospital from January 2015 to October 2017 were retrospectively analyzed. All patients underwent multi-disciplinary treatment(MDT)-directed conversion therapy, and D2 radical gastrectomy was performed after the disappearance of non-healing factors. The remission of patients after conversion therapy and the related intraoperative and postoperative indicators were analyzed. \u0000 \u0000 \u0000Results \u0000After the conversion therapy, there were 2 cases (8.7%) of complete remission, 13 cases (56.5%) of partial remission and 8 cases (34.8%) of stable disease. The remission rate of the conversion therapy was 65.2% (15/23). In all 23 cases, the surgical time was (135.5±32.1) min, the intraoperative blood loss was (356.7±101.3) ml, the number of lymph nodes resected was 35.5±10.3. The time of gastric tube indwelling was (70.5±29.6) h, the time to first liquid intake was (85.0±21.5) h, the time of drainage tube placement was (196.2±36.2) h and the postoperative hospital stay was (10.7±3.2) d. After surgery, two cases had grade ⅢA post-operative complications and 2 had gradeⅡ. All patients were followed up, the median progression-free survival time was 13.5 months and the median overall survival time was 21.9 months. \u0000 \u0000 \u0000Conclusion \u0000The survival time of patients with advanced gastric cancer can be prolonged by D2 radical gastrectomy after the MDT-guided conversion therapy. \u0000 \u0000 \u0000Key words: \u0000Gastric neoplasms; Surgical procedures, operative; Conversion therapy; Multi-disciplinary team","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"756-759"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49139416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress of biological characteristics of stress granules and their relationship with tumors 应激颗粒生物学特性及其与肿瘤关系的研究进展
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.11.016
Xianying Li, Dalong Yin, Lianxin Liu
Eukaryotes inhibit the translation of mRNA under stress conditions and form particles-stress granules (stress granules). At present, stress granules have been proved to be related to the occurrence and development of a variety of diseases, including tumors. The production of stress granules is promoted by microenvironment such as hypoxia and hyperactive oxygen in tumor cells, while stress granules-related proteins such as G3BP1, RACK1, YB-1 and mammalian target of rapamycin (mTOR) can promote the occurrence and metastasis of tumors, but the mechanism is not yet clear. In addition, studies have linked the formation of stress granules to the survival of tumor cells during chemotherapy, and believe that stress granules play a role in the treatment of tumors by different anti-tumor drugs. This review introduces the biological characteristics of stress granules and their relationship with tumors. Key words: Neoplasms; Stress granules; Antineoplastic drugs
真核细胞在应激条件下抑制信使核糖核酸的翻译并形成颗粒应激颗粒(应激颗粒)。目前,应激颗粒已被证明与包括肿瘤在内的多种疾病的发生和发展有关。肿瘤细胞中缺氧和高活性氧等微环境促进应激颗粒的产生,而应激颗粒相关蛋白G3BP1、RACK1、YB-1和哺乳动物雷帕霉素靶点(mTOR)可促进肿瘤的发生和转移,但其机制尚不清楚。此外,研究将应激颗粒的形成与化疗期间肿瘤细胞的存活联系起来,并认为应激颗粒在不同抗肿瘤药物治疗肿瘤中发挥作用。本文就应激颗粒的生物学特性及其与肿瘤的关系作一综述。关键词:肿瘤;应力颗粒;抗肿瘤药物
{"title":"Progress of biological characteristics of stress granules and their relationship with tumors","authors":"Xianying Li, Dalong Yin, Lianxin Liu","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.11.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.11.016","url":null,"abstract":"Eukaryotes inhibit the translation of mRNA under stress conditions and form particles-stress granules (stress granules). At present, stress granules have been proved to be related to the occurrence and development of a variety of diseases, including tumors. The production of stress granules is promoted by microenvironment such as hypoxia and hyperactive oxygen in tumor cells, while stress granules-related proteins such as G3BP1, RACK1, YB-1 and mammalian target of rapamycin (mTOR) can promote the occurrence and metastasis of tumors, but the mechanism is not yet clear. In addition, studies have linked the formation of stress granules to the survival of tumor cells during chemotherapy, and believe that stress granules play a role in the treatment of tumors by different anti-tumor drugs. This review introduces the biological characteristics of stress granules and their relationship with tumors. \u0000 \u0000 \u0000Key words: \u0000Neoplasms; Stress granules; Antineoplastic drugs","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"778-782"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42627554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of the human papillomavirus infection status and genotyping with the result of liquid-based thin-layer cytology of cervix in the female physical examiners in Xi'an 西安市女性体检者宫颈液基薄层细胞学检测结果与人乳头瘤病毒感染状况及分型的相关性
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.11.001
Hongyun Chang, Xiaofeng Li, Yuanyuan Wang, P. Nan, Xiao-meng Zhao
Objective To investigate the correlation of human papillomavirus (HPV) infection status and genotyping characteristics with the result of liquid-based thin-layer cytology (TCT) of the cervix in the female physical examiners in Xi'an. Methods The data of 5 163 female physical examiners who underwent HPV and TCT screening simultaneously in the First Affiliated Hospital of Xi'an Jiaotong University From June 2017 to June 2018 were collected to analyze HPV infection, genotyping and their relationship with TCT. Results Among the 5 163 examiners, 527 (10.21%) were HPV-positive, and the infection rate in the examiners over 60 years old was the highest [12.26% (57/465)]. Among HPV-positive examiners, the infection rate of single genotype was higher than that of multiple genotypes infection [75.90% (400/527) vs. 24.10% (127/527), P 0.05]. Among 50 examiners with positive results of HPV and TCT tests, the top four genotypes were type 58, 52, 53 and 16, and they were in consistence with the overall HPV infection genotyping. Conclusions The HPV infection in the female physical examiners in Xi'an is dominated by the single genotype infection, and the main genotypes of HPV infection are type 52, 58, 53 and 16. The combined detection of HPV genotyping and TCT can improve the effectiveness of cervical lesions screening. Key words: Human papillomavirus; Genotype; Cervical intraepithelial neoplasia; Liquid-based cytology; Xi'an
目的探讨西安市女性体检人员宫颈液体薄层细胞学检查结果与人乳头瘤病毒(HPV)感染状况及基因分型特征的相关性。方法收集2017年6月至2018年6月在西安交通大学第一附属医院同时进行HPV和TCT筛查的5 163名女性体检者的资料,分析HPV感染、基因分型及其与TCT的关系。结果5163名体检者中hpv阳性527人(10.21%),其中60岁以上体检者感染率最高[12.26%(57/465)]。hpv阳性检出者中,单基因型感染率高于多基因型感染率[75.90%(400/527)比24.10% (127/527),P < 0.05]。在50名HPV和TCT检测阳性的检查人员中,基因型最多的是58型、52型、53型和16型,与HPV感染总体基因分型一致。结论西安市女性体检人员HPV感染以单一基因型感染为主,主要基因型为52型、58型、53型和16型。HPV基因分型与TCT联合检测可提高宫颈病变筛查的有效性。关键词:人乳头瘤病毒;基因型;宫颈上皮内瘤变;液态细胞学;西安
{"title":"Correlation of the human papillomavirus infection status and genotyping with the result of liquid-based thin-layer cytology of cervix in the female physical examiners in Xi'an","authors":"Hongyun Chang, Xiaofeng Li, Yuanyuan Wang, P. Nan, Xiao-meng Zhao","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.11.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.11.001","url":null,"abstract":"Objective \u0000To investigate the correlation of human papillomavirus (HPV) infection status and genotyping characteristics with the result of liquid-based thin-layer cytology (TCT) of the cervix in the female physical examiners in Xi'an. \u0000 \u0000 \u0000Methods \u0000The data of 5 163 female physical examiners who underwent HPV and TCT screening simultaneously in the First Affiliated Hospital of Xi'an Jiaotong University From June 2017 to June 2018 were collected to analyze HPV infection, genotyping and their relationship with TCT. \u0000 \u0000 \u0000Results \u0000Among the 5 163 examiners, 527 (10.21%) were HPV-positive, and the infection rate in the examiners over 60 years old was the highest [12.26% (57/465)]. Among HPV-positive examiners, the infection rate of single genotype was higher than that of multiple genotypes infection [75.90% (400/527) vs. 24.10% (127/527), P 0.05]. Among 50 examiners with positive results of HPV and TCT tests, the top four genotypes were type 58, 52, 53 and 16, and they were in consistence with the overall HPV infection genotyping. \u0000 \u0000 \u0000Conclusions \u0000The HPV infection in the female physical examiners in Xi'an is dominated by the single genotype infection, and the main genotypes of HPV infection are type 52, 58, 53 and 16. The combined detection of HPV genotyping and TCT can improve the effectiveness of cervical lesions screening. \u0000 \u0000 \u0000Key words: \u0000Human papillomavirus; Genotype; Cervical intraepithelial neoplasia; Liquid-based cytology; Xi'an","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"721-724"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47232090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Grade IV myelosuppression induced by gemcitabine combined with cisplatin: report of one case and review of literature 吉西他滨联合顺铂诱导IV级骨髓抑制1例报告及文献复习
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.11.011
H. Zemin, Liu Keting, Yu Nanbin
目的 提高对吉西他滨致骨髓抑制的识别。 方法 回顾性分析自贡市第三人民医院收治的1例肺鳞状细胞癌患者在化疗时发生骨髓抑制的诊治过程,并复习相关文献。 结果 该患者以咳嗽伴咯血入院,行支气管镜病理诊断为右肺下叶肺鳞状细胞癌伴右侧胸膜转移,患者予多西他赛、奈达铂化疗后未见明显好转,改为吉西他滨、顺铂化疗,后出现Ⅳ级骨髓抑制,给予规范化治疗后骨髓抑制得到纠正。 结论 对于老年晚期癌症患者,应注意吉西他滨使用剂量;出现骨髓抑制后,在后续化疗方案中应注意调整剂量或推迟使用。
Objective: To improve the recognition of gemcitabine induced bone marrow suppression. Method: A retrospective analysis was conducted on the diagnosis and treatment process of bone marrow suppression during chemotherapy in a patient with lung squamous cell carcinoma admitted to the Third People's Hospital of Zigong City, and relevant literature was reviewed. The patient was admitted with cough and hemoptysis, and underwent bronchoscopy pathological diagnosis as squamous cell carcinoma of the lower lobe of the right lung with right pleural metastasis. The patient did not show significant improvement after receiving chemotherapy with docetaxel and nedaplatin, but switched to chemotherapy with gemcitabine and cisplatin. Later, grade IV bone marrow suppression occurred, and bone marrow suppression was corrected after receiving standardized treatment. Conclusion: For elderly patients with advanced cancer, attention should be paid to the dosage of gemcitabine used; After bone marrow suppression occurs, attention should be paid to adjusting the dosage or delaying use in subsequent chemotherapy plans.
{"title":"Grade IV myelosuppression induced by gemcitabine combined with cisplatin: report of one case and review of literature","authors":"H. Zemin, Liu Keting, Yu Nanbin","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.11.011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.11.011","url":null,"abstract":"目的 \u0000提高对吉西他滨致骨髓抑制的识别。 \u0000 \u0000 \u0000方法 \u0000回顾性分析自贡市第三人民医院收治的1例肺鳞状细胞癌患者在化疗时发生骨髓抑制的诊治过程,并复习相关文献。 \u0000 \u0000 \u0000结果 \u0000该患者以咳嗽伴咯血入院,行支气管镜病理诊断为右肺下叶肺鳞状细胞癌伴右侧胸膜转移,患者予多西他赛、奈达铂化疗后未见明显好转,改为吉西他滨、顺铂化疗,后出现Ⅳ级骨髓抑制,给予规范化治疗后骨髓抑制得到纠正。 \u0000 \u0000 \u0000结论 \u0000对于老年晚期癌症患者,应注意吉西他滨使用剂量;出现骨髓抑制后,在后续化疗方案中应注意调整剂量或推迟使用。","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"766-768"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41626711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of modified tracking components in CyberKnife treatment of thoracic and abdominal tumors 改良跟踪元件在射波刀治疗胸腹肿瘤中的应用
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.11.002
Guo-Quan Li, Yi Yu, Junping Cheng, Zhi-wen Liang, Xiao-le Zhu, S. Zhang, Zhen-jun Peng
Objective To improve synchrony tracking components of CyberKnife (tracking vest and tracking markers) and to analyze the clinical application value of the improved tracking components in CyberKnife treatment of thoracic and abdominal tumors. Methods The tracking apron was made of knitted four-side elastic spandex cloth and suture design of Velcro, which was used to stick the tracking markers on the chest and abdomen of patients. The tracking markers added a 2 cm thick light foam block to the bottom of the original markers, and then the hook face of the Velcro was fixed to the bottom of the light foam. The improved trace component (the improved component) and the original component (the vendor component) were applied to the lung tracking treatment model, and the manufacturer components were included in the reference group. Adoption of improved components into the observation group; 20 different types of respiratory waveforms were simulated and applied to the same mold plan. After treatment, the coverage rate, mean standard deviation, maximum standard deviation and the slope of XYZ-axis vs. R correlation graph were recorded. The relevant parameters of Synchrony model and wearable time of two components were compared, and the application significances of the improved tracking component in the breathing tracking process of the CyberKnife were evaluated. Results The maximum slope [median(interquartile range)] of XYZ-axis vs. R related graph in the reference group was 0.73 (3.89), 0.27 (0.49) and 0.34 (1.02), respectively. The maximum slope of XYZ-axis vs. R related graph in the observation group was 0.70 (2.78), 0.31 (0.30) and 0.36 (0.75), respectively. There was no statistically significant difference in the slope of XYZ-axis vs. R between the reference group and the observation group (all P > 0.05). There was no significant difference in the average standard error and maximum standard error between the reference group and the observation group [(1.7±0.4) mm vs. (1.7±0.5) mm, t=-0.382, P= 0.710; (2.0±0.6) mm vs. (1.7±0.5) mm, t=-0.877, P= 0.401], and the difference of the model coverage rate between the two groups was statistically significant [(48±18)% vs. (60±22)%, t= 2.762, P= 0.042]. The setup time of tracking components in the observation group was less than that in the reference group, and the difference was statistically significant [(44±24) s vs. (81±15) s, t=-4.310, P= 0.001]. Conclusions The improved tracking components are comparable to the manufacturer tracking components in the standard error of the Synchrony model. The improved components shorten the wear time and appropriately improve the coverage of the Synchrony model. Key words: Thoracic neoplasms; Abdominal neoplasms; CyberKnife; Stereotactic body radiation therapy; Standard error; Synchrony model
目的改进射波刀同步跟踪组件(跟踪背心和跟踪标记),分析改进后的跟踪组件在射波刀治疗胸腹肿瘤中的临床应用价值。方法采用针织四面弹性氨纶布制作跟踪围裙,采用尼龙搭扣缝合设计,将跟踪标记贴在患者胸腹两侧。跟踪标记在原标记的底部加一块2厘米厚的轻泡沫块,然后将魔术贴的钩面固定在轻泡沫的底部。将改进的微量成分(改良成分)和原始成分(供应商成分)应用于肺跟踪治疗模型,将制造商成分纳入参照组。观察组采用改良组件;模拟了20种不同类型的呼吸波形,并将其应用于同一模具平面。处理后记录复盖率、平均标准差、最大标准差及xyz轴与R相关图斜率。对比了同步模型的相关参数和两种组件的可穿戴时间,评价了改进后的跟踪组件在射波刀呼吸跟踪过程中的应用意义。结果参照组xyz轴与R相关图的最大斜率[中位数(四分位间距)]分别为0.73(3.89)、0.27(0.49)和0.34(1.02)。观察组xyz轴与R相关图的最大斜率分别为0.70(2.78)、0.31(0.30)、0.36(0.75)。对照组与观察组xyz轴斜率与R比较,差异均无统计学意义(P < 0.05)。对照组与观察组的平均标准误差和最大标准误差差异无统计学意义[(1.7±0.4)mm vs(1.7±0.5)mm, t=-0.382, P= 0.710;(2.0±0.6)mm vs(1.7±0.5)mm, t=-0.877, P= 0.401],两组模型覆盖率差异有统计学意义[(48±18)% vs(60±22)%,t= 2.762, P= 0.042]。观察组跟踪组件的设置时间短于参照组,差异有统计学意义[(44±24)s vs(81±15)s, t=-4.310, P= 0.001]。结论改进后的跟踪元件在Synchrony模型的标准误差上与制造商跟踪元件相当。改进后的部件缩短了磨损时间,并适当提高了同步模型的覆盖范围。关键词:胸部肿瘤;腹部肿瘤;射波刀;立体定向全身放射治疗;标准误差;同步模式
{"title":"Application of modified tracking components in CyberKnife treatment of thoracic and abdominal tumors","authors":"Guo-Quan Li, Yi Yu, Junping Cheng, Zhi-wen Liang, Xiao-le Zhu, S. Zhang, Zhen-jun Peng","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.11.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.11.002","url":null,"abstract":"Objective \u0000To improve synchrony tracking components of CyberKnife (tracking vest and tracking markers) and to analyze the clinical application value of the improved tracking components in CyberKnife treatment of thoracic and abdominal tumors. \u0000 \u0000 \u0000Methods \u0000The tracking apron was made of knitted four-side elastic spandex cloth and suture design of Velcro, which was used to stick the tracking markers on the chest and abdomen of patients. The tracking markers added a 2 cm thick light foam block to the bottom of the original markers, and then the hook face of the Velcro was fixed to the bottom of the light foam. The improved trace component (the improved component) and the original component (the vendor component) were applied to the lung tracking treatment model, and the manufacturer components were included in the reference group. Adoption of improved components into the observation group; 20 different types of respiratory waveforms were simulated and applied to the same mold plan. After treatment, the coverage rate, mean standard deviation, maximum standard deviation and the slope of XYZ-axis vs. R correlation graph were recorded. The relevant parameters of Synchrony model and wearable time of two components were compared, and the application significances of the improved tracking component in the breathing tracking process of the CyberKnife were evaluated. \u0000 \u0000 \u0000Results \u0000The maximum slope [median(interquartile range)] of XYZ-axis vs. R related graph in the reference group was 0.73 (3.89), 0.27 (0.49) and 0.34 (1.02), respectively. The maximum slope of XYZ-axis vs. R related graph in the observation group was 0.70 (2.78), 0.31 (0.30) and 0.36 (0.75), respectively. There was no statistically significant difference in the slope of XYZ-axis vs. R between the reference group and the observation group (all P > 0.05). There was no significant difference in the average standard error and maximum standard error between the reference group and the observation group [(1.7±0.4) mm vs. (1.7±0.5) mm, t=-0.382, P= 0.710; (2.0±0.6) mm vs. (1.7±0.5) mm, t=-0.877, P= 0.401], and the difference of the model coverage rate between the two groups was statistically significant [(48±18)% vs. (60±22)%, t= 2.762, P= 0.042]. The setup time of tracking components in the observation group was less than that in the reference group, and the difference was statistically significant [(44±24) s vs. (81±15) s, t=-4.310, P= 0.001]. \u0000 \u0000 \u0000Conclusions \u0000The improved tracking components are comparable to the manufacturer tracking components in the standard error of the Synchrony model. The improved components shorten the wear time and appropriately improve the coverage of the Synchrony model. \u0000 \u0000 \u0000Key words: \u0000Thoracic neoplasms; Abdominal neoplasms; CyberKnife; Stereotactic body radiation therapy; Standard error; Synchrony model","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"725-728"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48784801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of Erastin in ferroptosis Erastin在铁下垂中的作用
Q4 Medicine Pub Date : 2019-11-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.11.017
Yuechen Zhao, Lili Zhong, Yinlong Zhao
Ferroptosis is a newly discovered form of cell death in recent years. Its essence is the cell peroxidation death caused by the accumulation of intracellular lipid reactive oxygen species (L-ROS) in a iron-dependent manner. As a highly efficient ferroptosis inducer, Erastin mediates ferroptosis through multiple molecules, such as cystine-glutamate transport receptor, voltage-dependent anion channel and p53. More importantly, Erastin can enhance the sensitivity of cancer cells to chemotherapy and radiotherapy, so it can be used as a new type of anticancer drug. This article reviews the discovery of Erastin, the pathways of ferroptosis, the pathways of Erastin-induced ferroptosis, the anti-tumor characteristics of Erastin, and the latest domestic and international research results. Key words: Cell death; Antineoplastic combined chemotherapy protocols; Erastin; Ferroptosis
脱铁症是近年来新发现的一种细胞死亡形式。其本质是细胞内脂质活性氧(L-ROS)以铁依赖的方式积累引起的细胞过氧化死亡。Erastin作为一种高效的脱铁诱导剂,通过胱氨酸谷氨酸转运受体、电压依赖性阴离子通道和p53等多种分子介导脱铁。更重要的是,Erastin可以增强癌症细胞对化疗和放疗的敏感性,因此可以作为一种新型抗癌药物。本文综述了Erastin的发现、脱铁途径、Erastin诱导脱铁的途径、Erastin的抗肿瘤特性以及国内外最新研究成果。关键词:细胞死亡;抗肿瘤联合化疗方案;Erastin;铁下垂
{"title":"The role of Erastin in ferroptosis","authors":"Yuechen Zhao, Lili Zhong, Yinlong Zhao","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.11.017","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.11.017","url":null,"abstract":"Ferroptosis is a newly discovered form of cell death in recent years. Its essence is the cell peroxidation death caused by the accumulation of intracellular lipid reactive oxygen species (L-ROS) in a iron-dependent manner. As a highly efficient ferroptosis inducer, Erastin mediates ferroptosis through multiple molecules, such as cystine-glutamate transport receptor, voltage-dependent anion channel and p53. More importantly, Erastin can enhance the sensitivity of cancer cells to chemotherapy and radiotherapy, so it can be used as a new type of anticancer drug. This article reviews the discovery of Erastin, the pathways of ferroptosis, the pathways of Erastin-induced ferroptosis, the anti-tumor characteristics of Erastin, and the latest domestic and international research results. \u0000 \u0000 \u0000Key words: \u0000Cell death; Antineoplastic combined chemotherapy protocols; Erastin; Ferroptosis","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"782-786"},"PeriodicalIF":0.0,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45558770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Bisphosphonate-related osteonecrosis of the jaw in malignant tumor patients with bone metastases: clinical analysis of six cases 恶性肿瘤合并骨转移患者双膦酸盐相关性颌骨骨坏死6例临床分析
Q4 Medicine Pub Date : 2019-10-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.10.006
Pengfei Xin, Z. Tian, G. Xue
Objective To analyze the clinical manifestation, imaging characteristics and prevention of medication-related osteonecrosis of the jaw (MRONJ) after intravenous bisphosphonate (BP) for cancer patients with bone metastases. Methods The clinical data and radiographic findings of 6 primary breast cancer patients with bone metastases diagnosed as MRONJ from January 2014 to April 2018 in Shanxi Dayi Hospital were retrospectively analyzed. Results All 6 patients were female, with the median age of 65.5 years old. All patients had no history of systemic application of hormone therapy, no history of diabetes, no history of radiation therapy, no history of metastasis of the jaw, and no history of infection. The average usage time of BP was 28 months. MRONJ occurred in 2 cases on maxilla and 4 cases on mandible. There were 2 patients with tooth extractions history in BP treatment. Clinical symptoms included maxillofacial pain, loosened teeth, fistula suppuration, and exposed sequestrum. Radiographic findings included osteolysis and bone sclerosis or the mixed manifestation of both, with or without periosteal reaction. In addition, nonhealing tooth sockets and sequestrum separation imaging were also included. Conclusions Tooth extraction is considered as an increased risk for MRONJ in patients with malignant bone metastases after BP therapy. MRONJ is more likely to appear in the mandible, but it can also appear in the maxilla. Early screening and initiation of appropriate dental care are necessary for the patients before using BP therapy. Key words: Neoplasm metastasis; Diphosphonates; Skeleton; Medication-related osteonecrosis of the jaw
目的分析癌症骨转移患者静脉注射双磷酸盐(BP)后发生药物相关性颌骨坏死(MRONJ)的临床表现、影像学特点及预防措施。方法回顾性分析2014年1月至2018年4月在山西省大邑医院诊断为MRONJ的6例原发性癌症骨转移患者的临床资料和影像学表现。结果6例患者均为女性,中位年龄65.5岁。所有患者均无激素治疗全身应用史、糖尿病史、放射治疗史、颌骨转移史和感染史。BP的平均使用时间为28个月。MRONJ上颌骨2例,下颌骨4例。BP治疗有2例患者有拔牙史。临床症状包括颌面部疼痛、牙齿松动、瘘管化脓和暴露的螯合。影像学表现包括骨溶解和骨硬化或两者的混合表现,伴有或不伴有骨膜反应。此外,还包括未愈合的牙窝和骨隔离成像。结论BP治疗恶性骨转移患者后,拔牙被认为会增加MRONJ的风险。MRONJ更可能出现在下颌骨,但也可以出现在上颌骨。在使用BP治疗之前,有必要对患者进行早期筛查并开始适当的牙科护理。关键词:肿瘤转移;二膦酸盐;骨架;药物相关性颌骨坏死
{"title":"Bisphosphonate-related osteonecrosis of the jaw in malignant tumor patients with bone metastases: clinical analysis of six cases","authors":"Pengfei Xin, Z. Tian, G. Xue","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.10.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.10.006","url":null,"abstract":"Objective \u0000To analyze the clinical manifestation, imaging characteristics and prevention of medication-related osteonecrosis of the jaw (MRONJ) after intravenous bisphosphonate (BP) for cancer patients with bone metastases. \u0000 \u0000 \u0000Methods \u0000The clinical data and radiographic findings of 6 primary breast cancer patients with bone metastases diagnosed as MRONJ from January 2014 to April 2018 in Shanxi Dayi Hospital were retrospectively analyzed. \u0000 \u0000 \u0000Results \u0000All 6 patients were female, with the median age of 65.5 years old. All patients had no history of systemic application of hormone therapy, no history of diabetes, no history of radiation therapy, no history of metastasis of the jaw, and no history of infection. The average usage time of BP was 28 months. MRONJ occurred in 2 cases on maxilla and 4 cases on mandible. There were 2 patients with tooth extractions history in BP treatment. Clinical symptoms included maxillofacial pain, loosened teeth, fistula suppuration, and exposed sequestrum. Radiographic findings included osteolysis and bone sclerosis or the mixed manifestation of both, with or without periosteal reaction. In addition, nonhealing tooth sockets and sequestrum separation imaging were also included. \u0000 \u0000 \u0000Conclusions \u0000Tooth extraction is considered as an increased risk for MRONJ in patients with malignant bone metastases after BP therapy. MRONJ is more likely to appear in the mandible, but it can also appear in the maxilla. Early screening and initiation of appropriate dental care are necessary for the patients before using BP therapy. \u0000 \u0000 \u0000Key words: \u0000Neoplasm metastasis; Diphosphonates; Skeleton; Medication-related osteonecrosis of the jaw","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"670-674"},"PeriodicalIF":0.0,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41398774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angioimmunoblastic T-cell lymphoma with high expression of CD20: clinical characteristics and prognosis analysis of five cases CD20高表达血管免疫母细胞T细胞淋巴瘤5例临床特点及预后分析
Q4 Medicine Pub Date : 2019-10-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.10.013
Shao-jing Yang, Xiqing Chen, Zhuo Chen
目的 探讨CD20阳性血管免疫母细胞性T细胞淋巴瘤(AITL)的临床病理学特征。 方法 对广东省佛山市第一人民医院诊治的1例及文献报道的4例CD20阳性AITL患者的临床病理学特征及预后进行分析。 结果 5例AITL患者中,男性4例,女性1例,平均年龄61岁。3例初诊时CD20阴性,复发时才表达CD20。3例出现误诊,其中2例误诊为非特指型外周T细胞淋巴瘤,1例误诊为弥漫大B细胞淋巴瘤。3例接受利妥昔单抗治疗,2例有效,1例无法评估疗效。 结论 CD20阳性AITL患者的临床病理特征易与B细胞淋巴瘤混淆,病理形态学、免疫组织化学及TCR基因重排检测等可减少误诊。利妥昔单抗是否有益尚不明确,应积极寻找有效的治疗方案,提高治愈率,改善患者预后。
Objective To investigate the clinical and pathological characteristics of CD20 positive vascular immunoblastic T-cell lymphoma (AITL). Method: The clinical pathological characteristics and prognosis of one case of CD20 positive AITL diagnosed and treated at the First People's Hospital of Foshan City, Guangdong Province, and four cases reported in the literature were analyzed. Among the 5 AITL patients, there were 4 males and 1 female, with an average age of 61 years. Three cases were negative for CD20 at initial diagnosis and only expressed CD20 at recurrence. Three cases were misdiagnosed, of which two were misdiagnosed as non-specific peripheral T-cell lymphoma and one was misdiagnosed as diffuse large B-cell lymphoma. 3 cases received rituximab treatment, 2 cases were effective, and 1 case was unable to evaluate the efficacy. Conclusion: The clinical pathological characteristics of CD20 positive AITL patients are easily confused with B-cell lymphoma, and pathological morphology, immunohistochemistry, and TCR gene rearrangement testing can reduce misdiagnosis. It is not yet clear whether rituximab is beneficial, and effective treatment plans should be actively sought to improve the cure rate and patient prognosis.
{"title":"Angioimmunoblastic T-cell lymphoma with high expression of CD20: clinical characteristics and prognosis analysis of five cases","authors":"Shao-jing Yang, Xiqing Chen, Zhuo Chen","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.10.013","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.10.013","url":null,"abstract":"目的 \u0000探讨CD20阳性血管免疫母细胞性T细胞淋巴瘤(AITL)的临床病理学特征。 \u0000 \u0000 \u0000方法 \u0000对广东省佛山市第一人民医院诊治的1例及文献报道的4例CD20阳性AITL患者的临床病理学特征及预后进行分析。 \u0000 \u0000 \u0000结果 \u00005例AITL患者中,男性4例,女性1例,平均年龄61岁。3例初诊时CD20阴性,复发时才表达CD20。3例出现误诊,其中2例误诊为非特指型外周T细胞淋巴瘤,1例误诊为弥漫大B细胞淋巴瘤。3例接受利妥昔单抗治疗,2例有效,1例无法评估疗效。 \u0000 \u0000 \u0000结论 \u0000CD20阳性AITL患者的临床病理特征易与B细胞淋巴瘤混淆,病理形态学、免疫组织化学及TCR基因重排检测等可减少误诊。利妥昔单抗是否有益尚不明确,应积极寻找有效的治疗方案,提高治愈率,改善患者预后。","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"700-703"},"PeriodicalIF":0.0,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41552804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application value of artificial intelligence-assisted diagnosis model in ultrasound diagnosis of breast nodules 人工智能辅助诊断模型在乳腺结节超声诊断中的应用价值
Q4 Medicine Pub Date : 2019-10-28 DOI: 10.3760/CMA.J.ISSN.1006-9801.2019.10.001
H. Ji, Qiang Zhu, Conggui Gan, Shuai Zhou, Yun Cheng, Mingchang Zhao
Objective To explore the application value of the convolutional neural network (CNN)-based artificial intelligence-assisted diagnosis model in the ultrasound differentiation diagnosis of benign and malignant breast nodules. Methods A total of 7 334 ultrasound images from 1 351 patients with breast nodules including 807 benign cases and 544 malignant cases were retrieved by using the CNN-based artificial intelligence-assisted diagnosis model from Beijing Tongren Hospital of Capital Medical University ultrasound images database between December 2006 and July 2017. The study included training subset (6 162 images), verification subset (555 images), and test subset (617 images), which were performed in the artificial intelligence-assisted diagnosis model. The outcome results of test subset in diagnosis model were compared with the pathological results. The sensitivity, specificity and accuracy of the artificial intelligence-assisted diagnosis model were calculated. Results After the test of 617 images, the model diagnostic results could be automatically output with a rectangular frame indicating the nodule position, benign and malignant diagnosis, benign and malignant probability values. The diagnosis time was approximately 4 seconds for each nodule. The sensitivity, specificity and accuracy of the diagnostic model in differentiating benign and malignant breast nodules were 84.1%, 95.0% and 91.2% , respectively. Conclusion The CNN-based artificial intelligence-assisted diagnosis model has satisfactory results in the differentiation diagnosis of the benign breast nodules and the malignant ones, which indicating the promising application prospect. Key words: Breast neoplasms; Convolutional neural network; Artificial intelligence; Auxiliary diagnosis
目的探讨基于卷积神经网络(CNN)的人工智能辅助诊断模型在乳腺良恶性结节超声鉴别诊断中的应用价值。方法利用基于cnn的人工智能辅助诊断模型,从首都医科大学附属北京同仁医院超声图像数据库中检索2006年12月至2017年7月1 351例乳腺结节患者的7 334张超声图像,其中良性807例,恶性544例。该研究包括训练子集(6 162张图像)、验证子集(555张图像)和测试子集(617张图像),在人工智能辅助诊断模型中进行。将诊断模型试验亚群结果与病理结果进行比较。计算人工智能辅助诊断模型的灵敏度、特异性和准确性。结果617张图像检测后,模型诊断结果可自动输出,并以矩形框显示结节位置、良恶性诊断、良恶性概率值。每个结节的诊断时间约为4秒。诊断模型鉴别乳腺良恶性结节的敏感性、特异性和准确性分别为84.1%、95.0%和91.2%。结论基于cnn的人工智能辅助诊断模型在乳腺良性结节与恶性结节的鉴别诊断中取得了满意的结果,具有广阔的应用前景。关键词:乳腺肿瘤;卷积神经网络;人工智能;辅助诊断
{"title":"Application value of artificial intelligence-assisted diagnosis model in ultrasound diagnosis of breast nodules","authors":"H. Ji, Qiang Zhu, Conggui Gan, Shuai Zhou, Yun Cheng, Mingchang Zhao","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.10.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.10.001","url":null,"abstract":"Objective \u0000To explore the application value of the convolutional neural network (CNN)-based artificial intelligence-assisted diagnosis model in the ultrasound differentiation diagnosis of benign and malignant breast nodules. \u0000 \u0000 \u0000Methods \u0000A total of 7 334 ultrasound images from 1 351 patients with breast nodules including 807 benign cases and 544 malignant cases were retrieved by using the CNN-based artificial intelligence-assisted diagnosis model from Beijing Tongren Hospital of Capital Medical University ultrasound images database between December 2006 and July 2017. The study included training subset (6 162 images), verification subset (555 images), and test subset (617 images), which were performed in the artificial intelligence-assisted diagnosis model. The outcome results of test subset in diagnosis model were compared with the pathological results. The sensitivity, specificity and accuracy of the artificial intelligence-assisted diagnosis model were calculated. \u0000 \u0000 \u0000Results \u0000After the test of 617 images, the model diagnostic results could be automatically output with a rectangular frame indicating the nodule position, benign and malignant diagnosis, benign and malignant probability values. The diagnosis time was approximately 4 seconds for each nodule. The sensitivity, specificity and accuracy of the diagnostic model in differentiating benign and malignant breast nodules were 84.1%, 95.0% and 91.2% , respectively. \u0000 \u0000 \u0000Conclusion \u0000The CNN-based artificial intelligence-assisted diagnosis model has satisfactory results in the differentiation diagnosis of the benign breast nodules and the malignant ones, which indicating the promising application prospect. \u0000 \u0000 \u0000Key words: \u0000Breast neoplasms; Convolutional neural network; Artificial intelligence; Auxiliary diagnosis","PeriodicalId":9505,"journal":{"name":"Cancer Research and Clinic","volume":"31 1","pages":"649-652"},"PeriodicalIF":0.0,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45020627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
肿瘤研究与临床
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1